glp 1 in mounjaro GLP-1 use tripled among non-diabetics, reaching $5.8B 2022 GLP-1 Tirzepatide Bangkok: Mounjaro Guide

The LSMS voted no as a policyholder, exercising its equity claim in BCBSLA that appears to be unprecedented

No hard-to-swallow pills, no fillers, no compromise.

investigated the dose-dependent hepatotoxic effects of subcutaneously injected EGCG (55, 70, and 125 mg/kg/day) in mice (229)

PlexusDx recommends optimizing your tirzepatide dose and dosing schedule before considering unproven adjuncts

Limited peptide manufacturing capacity is likely to keep supply tight until new facilities reach full output in 2027

But list price is only the starting line it comes before insurance, rebates, manufacturer savings cards, and pharmacy negotiation ever touch the total